Prospective Episealer Talus Study 50% Recruited

Fifty percent of the patients have been recruited to a prospective study of Episurf Medical's Episealer Talus® implant in Italy.

The study will follow 15 patients who received an Episealer Talus implant as treatment for osteochondral defects in the ankle. Episealer Talus is Episurf Medical’s CE-Marked implant technology, intended for the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us